Taomics Inc.

Taomics is creating a research platform that combines longitudinal multi-omics with real-world lifestyle data to understand how health changes and how interventions may help. Working with Japanese universities and local stakeholders, we are expanding a re-contactable cohort in Japan. Pilot tracking began in 2024, with the full 1,000-participant stage starting in 2026. Multi-omics data (including genome and proteome) are collected alongside continuous lifestyle data via the Taohealth app and wearables. By integrating these data with AI, we build digital twins that model biological networks and identify drivers associated with aging and health related score.

For organizations, our Validation and Research Platform accelerates evidence generation for products in pharma, biotech, food, supplements, and devices, supported by commercial-ready governance.

For individuals, our Personal Healthcare Program translates multi-omics and lifestyle data into actionable insights and personalized plans delivered with partner clinics. We are seeking global partners to co-design pilots and validate interventions that can scale from Japan to international markets.